| pubmed-article:11070990 | pubmed:abstractText | Serum PSA has been commercially available for more than ten years, and has proved to be the most important tumour marker for prostate cancer. We review the clinical usefulness and limitations of serum PSA as a tumour marker of prostate cancer. | lld:pubmed |
